AIDS International Training and Research Program (AITRP)

$1,057,030D43FY2007TWNIH

University Of California Berkeley, Berkeley CA

Investigators

Linked publications & trials

Paper 27708985 Paper 26379067 Paper 26108012 Paper 25996287 Paper 25118796 Paper 25065834 Paper 24959962 Paper 24802651 Paper 24368930 Paper 24327184 Paper 24154655 Paper 24101099 Paper 24039704 Paper 24021306 Paper 23986273 Paper 23975474 Paper 23963499 Paper 23959143 Paper 23955660 Paper 23877790 Paper 23857356 Paper 23807077 Paper 23791426 Paper 23754614 Paper 23722975 Paper 23695521 Paper 23695520 Paper 23695518 Paper 23643180 Paper 23614994 Paper 23547778 Paper 23409198 Paper 23305161 Paper 23197431 Paper 23186171 Paper 23118494 Paper 22571110 Paper 22453048 Paper 22404277 Paper 22337108 Paper 22279129 Paper 22269018 Paper 22195036 Paper 22186382 Paper 22089604 Paper 21968460 Paper 21880743 Paper 21844747 Paper 21541358 Paper 21525339 Paper 21393886 Paper 21301949 Paper 21222586 Paper 20716343 Paper 20635247 Paper 20397872 Paper 20375927 Paper 20143397 Paper 20089995 Paper 19940809 Paper 19917204 Paper 19903291 Paper 19824915 Paper 19778295 Paper 19762673 Paper 19649263 Paper 19590406 Paper 19484616 Paper 19477476 Paper 19432554 Paper 19430307 Paper 19392745 Paper 19301113 Paper 19283635 Paper 19142438 Paper 19105884 Paper 18800244 Paper 18777222 Paper 18708735 Paper 18664281 Paper 18521737 Paper 18500658 Paper 18453858 Paper 18448504 Paper 18445948 Paper 18427972 Paper 18401700 Paper 18389359 Paper 18389357 Paper 18389356 Paper 18365006 Paper 18360743 Paper 18337332 Paper 18284466 Paper 18176326 Paper 17973997 Paper 17968647 Paper 17957262 Paper 17726535 Paper 17670829

Abstract

We will provide multi-disciplinary training to physicians, dentists, pharmacists, scientists, and support personnel from selected developing countries in research methods relevant to epidemiological and behavioral studies related to AIDS, HIV transmission, interventions designed to prevent AIDS/HIV transmission, and treatment to prevent or delay morbidity and mortality in HIV-infected persons. Highest priority will be given to training individuals involved in collaborative research projects designed to prevent sexual transmission of HIV via treatment of other sexually transmitted diseases and behavioral or structural interventions; projects testing the efficacy of new HIV vaccines; projects examining how best to use anti-retroviral drug regimens to treat HIV-infected persons and monitor outcomes in resource constrained settings; and projects aimed at improving the prevention and the treatment of tuberculosis and other opportunistic conditions in HIV-infected individuals. Training will be available in planning, managing, and analyzing data from AIDS-related clinical trials and HIV vaccine trials; epidemiological and behavioral research relevant to AIDS, HIV transmission, sexually transmitted diseases and tuberculosis virology, immunology, serology, and other diagnostic methods related to AIDS/HIV; clinical microbiology related to sexually transmitted diseases, tuberculosis, and other opportunistic infections; and the ethical issues involved in human research in general, and AIDS-related research in other countries in particular. In all instances in which U.S. faculty are assigned to be in country for training and supervision of trainees they will be situated in host institutions conducting high quality, ongoing collaborative AIDS research, particularly research dealing with behavioral and structural interventions designed to prevent transmission of HIV; HIV vaccine trials; and clinical trials of drugs given to treat HIV infection and AIDS, including anti-retroviral drug regimens. [unreadable]

View original record on NIH RePORTER →